Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (41-50 of 275) with videos related to

Pageof 28
Sort By:
Urologic Oncology|September 11, 2007
RhoGDI2: a new metastasis suppressor gene: discovery and clinical translationMichael A Harding, Dan Theodorescu
Thescientificworldjournal|July 11, 2007
Robot-assisted radical cystectomy in the management of bladder cancerJessica L Keim, Dan Theodorescu
European Urology|November 5, 2013
Telomerase in bladder cancer: back to a better future?Dan Theodorescu, Thomas R Cech
Urologic Oncology|December 24, 2013
Pharmacogenomics in bladder cancerGarrett M Dancik, Dan Theodorescu
Pharmacogenomics|July 27, 2017
Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancerTahlita Cm Zuiverloon, Dan Theodorescu
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder CancerGarrett M Dancik, Dan Theodorescu
World Journal of Urology|October 26, 2006
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomasChristopher Y Thomas, Dan Theodorescu
The Journal of Urology|October 31, 2006
Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesisChristopher Y Thomas, Dan Theodorescu
Biochemical and Biophysical Research Communications|August 21, 2007
Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76)Mikael C Herlevsen, Dan Theodorescu
Urologic Oncology|July 24, 2004
When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancerDan Theodorescu, Henry F Frierson
Pageof 28

Showing results (41-50 of 275) with videos related to

Sort By:
Pageof 28
Urologic Oncology|September 11, 2007
RhoGDI2: a new metastasis suppressor gene: discovery and clinical translationMichael A Harding, Dan Theodorescu
Thescientificworldjournal|July 11, 2007
Robot-assisted radical cystectomy in the management of bladder cancerJessica L Keim, Dan Theodorescu
European Urology|November 5, 2013
Telomerase in bladder cancer: back to a better future?Dan Theodorescu, Thomas R Cech
Urologic Oncology|December 24, 2013
Pharmacogenomics in bladder cancerGarrett M Dancik, Dan Theodorescu
Pharmacogenomics|July 27, 2017
Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancerTahlita Cm Zuiverloon, Dan Theodorescu
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder CancerGarrett M Dancik, Dan Theodorescu
World Journal of Urology|October 26, 2006
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomasChristopher Y Thomas, Dan Theodorescu
The Journal of Urology|October 31, 2006
Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesisChristopher Y Thomas, Dan Theodorescu
Biochemical and Biophysical Research Communications|August 21, 2007
Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76)Mikael C Herlevsen, Dan Theodorescu
Urologic Oncology|July 24, 2004
When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancerDan Theodorescu, Henry F Frierson
Pageof 28